Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)
Taiwan · Delayed Price · Currency is TWD 29.35
-0.35 (-1.18%)
Apr 17, 2026, 1:30 PM CST
TPE:1762 Revenue
In the year 2025, Chunghwa Chemical Synthesis & Biotech had annual revenue of 804.88M TWD, down -40.26%. Chunghwa Chemical Synthesis & Biotech had revenue of 113.42M in the quarter ending December 31, 2025, a decrease of -60.39%.
Revenue
804.88M
Revenue Growth
-40.26%
P/S Ratio
2.80
Revenue / Employee
4.07M
Employees
198
Market Cap
2.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 804.88M | -542.50M | -40.26% |
| Dec 31, 2024 | 1.35B | -739.07M | -35.42% |
| Dec 31, 2023 | 2.09B | -30.70M | -1.45% |
| Dec 31, 2022 | 2.12B | 182.44M | 9.43% |
| Dec 31, 2021 | 1.93B | 391.11M | 25.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Synbio Tech | 1.04B |
| Genomics BioSci & Tech. | 708.38M |
| G&E Herbal Biotechnology | 309.13M |
| Sunny Pharmtech | 290.18M |
| 3D Global Biotech | 206.74M |
| Gwo Xi Stem Cell Applied Technology Co. , | 187.02M |
| GlycoNex Incorporation | 37.86M |
| TaiRx | 27.88M |